579 related articles for article (PubMed ID: 12832972)
21. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
[TBL] [Abstract][Full Text] [Related]
22. Expression of cytokeratin-20 in pancreatic cancer: an indicator of poor outcome after R0 resection.
Schmitz-Winnenthal FH; Volk C; Helmke B; Berger S; Hinz U; Koch M; Weitz J; Kleeff J; Friess H; Zöller M; Büchler MW; Z'graggen K
Surgery; 2006 Jan; 139(1):104-8. PubMed ID: 16364723
[TBL] [Abstract][Full Text] [Related]
23. Recurrence of exocrine pancreatic cancer--local or hepatic?
Westerdahl J; Andrén-Sandberg A; Ihse I
Hepatogastroenterology; 1993 Aug; 40(4):384-7. PubMed ID: 8406311
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
Katsuragi K; Yashiro M; Sawada T; Osaka H; Ohira M; Hirakawa K
Br J Cancer; 2007 Aug; 97(4):550-6. PubMed ID: 17667927
[TBL] [Abstract][Full Text] [Related]
25. Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer.
Yachida S; Fukushima N; Sakamoto M; Matsuno Y; Kosuge T; Hirohashi S
Br J Surg; 2002 May; 89(5):573-8. PubMed ID: 11972546
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic hepatic irradiation following curative resection of pancreatic cancer.
Hishinuma S; Ogata Y; Tomikawa M; Ozawa I; Inoue K; Katano S; Tsukiyama I
J Hepatobiliary Pancreat Surg; 2005; 12(3):235-42. PubMed ID: 15995813
[TBL] [Abstract][Full Text] [Related]
27. Is peritoneal cytology a predictor of unresectability in pancreatic carcinoma?
Schmidt J; Fraunhofer S; Fleisch M; Zirngibl H
Hepatogastroenterology; 2004; 51(60):1827-31. PubMed ID: 15532836
[TBL] [Abstract][Full Text] [Related]
28. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
[TBL] [Abstract][Full Text] [Related]
29. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma.
Van den Broeck A; Sergeant G; Ectors N; Van Steenbergen W; Aerts R; Topal B
Eur J Surg Oncol; 2009 Jun; 35(6):600-4. PubMed ID: 19131205
[TBL] [Abstract][Full Text] [Related]
30. Potentially curative resection for locoregional recurrence of colorectal cancer.
Fuzun M; Terzi C; Sokmen S; Unek T; Haciyanli M
Surg Today; 2004; 34(11):907-12. PubMed ID: 15526124
[TBL] [Abstract][Full Text] [Related]
31. The influence of histopathologic criteria on the long-term prognosis of locally excised pT1 rectal carcinomas: results of local excision (transanal endoscopic microsurgery) and immediate reoperation.
Borschitz T; Heintz A; Junginger T
Dis Colon Rectum; 2006 Oct; 49(10):1492-506; discussion 1500-5. PubMed ID: 16897336
[TBL] [Abstract][Full Text] [Related]
32. Treatment of locoregional recurrence after intentional curative resection of pancreatic cancer.
Menke-Pluymers MB; Klinkenbijl JH; Tjioe M; Jeekel J
Hepatogastroenterology; 1992 Oct; 39(5):429-32. PubMed ID: 1459525
[TBL] [Abstract][Full Text] [Related]
33. Redo-surgery following curative resection of pancreatic carcinoma: the difference between true and suspected recurrence.
Seelig MH; Janot M; Chromik AM; Herzog T; Belyaev O; Weyhe D; Meurer K; Meiser A; Tannapfel A; Uhl W
Dig Surg; 2009; 26(3):222-8. PubMed ID: 19468232
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
[TBL] [Abstract][Full Text] [Related]
35. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
Bowne WB; Lee B; Wong WD; Ben-Porat L; Shia J; Cohen AM; Enker WE; Guillem JG; Paty PB; Weiser MR
Dis Colon Rectum; 2005 May; 48(5):897-909. PubMed ID: 15785892
[TBL] [Abstract][Full Text] [Related]
36. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of peritoneal cytology and the combination of peritoneal cytology and peritoneal dissemination in colorectal cancer.
Nishikawa T; Watanabe T; Sunami E; Tsuno NH; Kitayama J; Nagawa H
Dis Colon Rectum; 2009 Dec; 52(12):2016-21. PubMed ID: 19934924
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal cytology in the surgical evaluation of gastric carcinoma.
Hayes N; Wayman J; Wadehra V; Scott DJ; Raimes SA; Griffin SM
Br J Cancer; 1999 Feb; 79(3-4):520-4. PubMed ID: 10027323
[TBL] [Abstract][Full Text] [Related]
39. Liver metastases after curative resection in patients with distal bile duct cancer.
Takao S; Shinchi H; Uchikura K; Kubo M; Aikou T
Br J Surg; 1999 Mar; 86(3):327-31. PubMed ID: 10201773
[TBL] [Abstract][Full Text] [Related]
40. The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer.
Kang CM; Kim JY; Choi GH; Kim KS; Choi JS; Lee WJ; Kim BR
J Surg Res; 2007 Jun; 140(1):31-5. PubMed ID: 17418869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
